Search Results

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

What Is Your Preferred EVAR Device and Why?

By Michael J. Singh, MD, FACS, RPVI; Sharif Ellozy, MD; Mark K. Eskandari, MD, FACS; Ross Milner, MD; Ronald M. Fairman, MD; and Peter R. Nelson, MD, MS

Ask the Experts: What SFA Trials Would You Most Like to See?

Experts discuss key questions to answer, potential trial designs, and the likelihood that the trials will be undertaken.

With Peter A. Schneider, MD; Thomas Zeller, MD; Osamu Iida, MD; Marianne Brodmann, MD; Krishna Rocha-Singh, MD; and Christopher Metzger, MD

PE Response Teams: Evolution Within the Revolution

Early adopters of the PERT concept share practical insights on forming an effective team.

Moderator: Rachel P. Rosovsky, MD, MPH;
Panelists: George Davis, PharmD; James Horowitz, MD; Brent Keeling, MD; Vicki McNally, MSN, RN, NP; John Moriarty, MD, FSIR; Soophia Naydenov, MD, FCCP; Fionnuala Ní Áinle, MD, PhD; and Charles B. Ross, MD, FACS, DFSVS

Assessing Carotid Stenting

By Barry T. Katzen, MD, Chief Medical Editor

Meeting the Challenge

By Barry T. Katzen, MD, Chief Medical Editor

All Eyes on TEVAR

By Takao Ohki, MD, PhD

A Tectonic Paradigm Shift

By Takao Ohki, MD, PhD, Chief Medical Editor

The Good, the Bad, and the Ugly

By John R. Laird, Jr, MD, Chief Medical Editor

Residual Type B Aortic Dissection With Worsening Renal Malperfusion

Moderator: Joseph Lombardi, MD
Panelists: Adam Beck, MD; G. Chad Hughes, MD; and Darren Schneider, MD

Raising Critical Questions

Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD, discusses the questions she posed to the EVA-3S and SPACE presenters at VEITH, the difference between failure to show noninferiority and superiority, and critical aspects of future trial design.

By Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD